Mano Nakamura Selected Research

Mano Nakamura Research Topics

12	Neoplasms (Cancer) 01/2023 - 01/2017
7	Melanoma (Melanoma, Malignant) 01/2023 - 01/2017
3	Ovarian Neoplasms (Ovarian Cancer) 01/2023 - 01/2017
2	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2017
2	Hypersensitivity (Allergy) 10/2020 - 01/2020
1	Mycosis Fungoides 03/2024
1	Anaphylaxis (Anaphylactic Shock) 01/2023
1	Autoimmune Diseases (Autoimmune Disease) 01/2023
1	Urticaria (Hives) 01/2023
1	Bacterial Infections (Bacterial Infection) 11/2020
1	Immediate Hypersensitivity 10/2020
1	Inflammation (Inflammations) 01/2019
1	Mesothelioma 01/2017
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2017
1	Breast Neoplasms (Breast Cancer) 01/2017
1	Neuroblastoma 01/2017
1	Sarcoma (Soft Tissue Sarcoma) 01/2017

6	Immunoglobulin E (IgE)IBA 01/2023 - 01/2017
5	AntibodiesIBA 01/2023 - 01/2017
4	AntigensIBA 01/2023 - 01/2019
2	chondroitin sulfate proteoglycan 4IBA 01/2023 - 01/2017
2	Fc Receptors (Fc Receptor)IBA 01/2023 - 01/2017
2	Monoclonal AntibodiesIBA 01/2021 - 11/2020
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2020
1	Brentuximab VedotinIBA 03/2024
1	Folate Receptor 1IBA 01/2023
1	AutoantigensIBA 01/2023
1	Complementarity Determining Regions (Complementarity Determining Region)IBA 01/2023
1	IpilimumabIBA 01/2021
1	NivolumabIBA 01/2021
1	Death Domain ReceptorsIBA 01/2021
1	pembrolizumabIBA 01/2021
1	Immune Checkpoint ProteinsIBA 01/2021
1	Tryptases (Tryptase)IBA 01/2020
1	cyclopropapyrroloindoleIBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2020
1	HaptoglobinsIBA 01/2019
1	ApolipoproteinsIBA 01/2019
1	Immune Checkpoint InhibitorsIBA 01/2019
1	Blocking AntibodiesIBA 01/2019
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 09/2017
1	Mitogen-Activated Protein KinasesIBA 09/2017
1	Antiparasitic Agents (Antiparasitics)IBA 01/2017
1	Immunoglobulin G (IgG)IBA 01/2017
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2017
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2017

6	Therapeutics 01/2023 - 09/2017
4	Immunotherapy 01/2023 - 01/2017